Vistin Pharma ASA: Mandatory notification of trade

May 31, 2023 Off By GlobeNewswire

Ferncliff Listed DAI AS has on 30 May 2023 purchased 250,000 shares in Vistin Pharma ASA at NOK 23.12 per share. After the transaction Ferncliff Listed DAI AS has a holding of 1,034,280 shares, corresponding to 2,33% ownership. Ferncliff Listed DAI AS are closely associated with board member Øystein Stray Spetalen.
Attachment

20230530_Notification of trade_Ferncliff i Vistin